Search Results 891-900 of 13506 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  2. Mild cognitive impairment - Diagnosis and treatment - Mayo Clinic

    Known as monoclonal antibodies, they include: Lecanemab-irmb (Leqembi). This medicine is given as an IV infusion every two weeks. It can cause infusion ...

  3. Liver Cancer Clinical Trials - Mayo Clinic Research

    Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  4. Publications - Aditya K. Ghosh, M.D. - Mayo Clinic

    Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19). Obstet Gynecol 2022 Apr 1; 139 (4):616 ...

  5. Acute Myelogenous Leukemia Clinical Trials - Mayo Clinic Research

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  6. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  7. Metastatic (Stage 4) Breast Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as ... Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan.

  8. Publications - Jorge A. Trejo-Lopez, M.D. - Mayo Clinic

    Antineutrophilic Cytoplasmic Antibody-Related Spinal Pachymeningitis. ... Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein.

  9. A Study To Evaluate The Safety And Effectiveness Of ALLO-501A CAR T Cell Therapy In Adults With Relapsed/ Refractory Large B Cell Lymphoma - Mayo Clinic

    At least 2 prior lines of chemotherapy including an anthracycline and an anti-CD20 monoclonal antibody. Prior CD19 therapy allowed with evidence of CD19 ...

  10. Doctors & Departments - Mayo Clinic

    This includes combining bispecific antibodies with other powerful therapies and replacing traditional therapies with newer bispecific antibody-based therapies.